Recombinant oncolytic herpes simplex virus type Ⅰ (R130) Clinical Trials
2 recruitingDrug
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Soft Tissue SarcomaSarcomaOsteosarcoma+1 more
Shanghai Yunying Medical Technology9 enrolled1 locationNCT06171282
Recruiting
Early Phase 1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
SarcomaOsteosarcomaSarcoma,Soft Tissue+1 more
Shanghai Yunying Medical Technology20 enrolled1 locationNCT05851456